IOSP
Strong BuyPremium GrowerAI neutralInnospec Inc. · Basic Materials · United States · $2.4B cap · $24.8M/day traded
$98.64 -0.0% · close 23 Oct · scored 24 Oct
Premium Grower: Strong business with the market behind it, priced at a premium.
Report expected 3 Nov: the next-year EPS estimate has risen 1.4% over the last 14 weeks.
As of 24 Oct 2026, MoatMap's StockRank for Innospec Inc. (IOSP) is 89/100, ranked against 24,000+ stocks in 35 markets (Quality 70, Value 44, Momentum 76, each scored against its sector).
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Innospec makes fuel additives, personal-care ingredients and oilfield chemicals, with a net-cash balance sheet, an active buyback and a second quarter that showed growth across all segments. Tighter fuel markets support demand for performance additives and oilfield chemicals. The business is solid but the reinvestment runway is modest, and recent commentary about possible buyers suggests some takeover interest may already be in the price.
ABOUT INNOSPEC INC.
Read
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0B | 1.9B | 1.8B | 1.8B | -3.3% | 1.8B | 1.9B | 2.0B | 6.5% |
| EPS | 5.37 | 5.60 | 1.43 | 4.69 | -4.4% | 4.90 | 4.38 | 5.49 | 8.2% |
| Shares | 24.8M | 24.9M | 25.0M | 24.8M | +0.0% | 24.6M | — | — | — |
| Debt | 45.3M | 45.2M | 44.9M | 52.7M | 5.2% | 47.9M | — | — | — |
| Equity | 1.0B | 1.1B | 1.2B | 1.3B | 8.5% | — | — | — | — |
| Op CF | 81.7M | 207.3M | 184.5M | 138.3M | 19.2% | 124.3M | — | — | — |
| Inv CF | -42.1M | -111.8M | -62.0M | -75.1M | — | — | — | — | — |
| Fin CF | -33.7M | -39.0M | -35.3M | -63.9M | — | — | — | — | — |
Above its 200-day average and 2% below its 52-week high.
Calmer than 86% of stocks we rank over the past year (23% a year).
How this is worked out
StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.
The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of IOSP are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IOSP | Innospec Inc.(you) | $2.4B | 89 | Strong Buy |
| AVNT | Avient Corporation | $3.8B | 84 | Strong Buy |
| CBT | Cabot Corporation | $3.8B | 82 | Strong Buy |
| ASH | Ashland Inc. | $3.3B | 79 | Buy |
| NGVT | Ingevity Corporation | $2.4B | 69 | Buy |
| KWR | Quaker Chemical Corporation | $2.7B | 69 | Buy |
| SCL | Stepan Company | $1.5B | 77 | Buy |
| MATV | Mativ Holdings, Inc. | $666M | 90 | Strong Buy |
| FUL | H.B. Fuller Company | $2.7B | 65 | Hold |
| WDFC | WD-40 Company | $2.9B | 66 | Buy |
Peer medians: ROE 1.6% · P/E 20.6x · Gross margin 27.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.